Global Pharmaceuticals & Biotech Undervalued Small Caps

Consun Pharmaceutical Group

Market Cap: HK$12.7b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

CorMedix

Market Cap: US$910.4m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Hugel

Market Cap: ₩2.8t

Develops and manufactures biopharmaceuticals in South Korea and internationally.

Cosmo Pharmaceuticals

Market Cap: CHF 1.1b

Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.

Duopharma Biotech Berhad

Market Cap: RM 1.2b

An investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally.

Marksans Pharma

Market Cap: ₹82.5b

Engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally.

Zhejiang Jolly PharmaceuticalLTD

Market Cap: CN¥12.1b

Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.

Abeona Therapeutics

Market Cap: US$260.5m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

Genomma Lab Internacional. de

Market Cap: Mex$17.8b

Provides pharmaceutical and personal care products primarily in Mexico and internationally.

China Resources Boya Bio-pharmaceutical GroupLtd

Market Cap: CN¥12.7b

Engages in the blood product businesses in China.

Beijing Strong BiotechnologiesInc

Market Cap: CN¥8.0b

Researches, develops, manufactures, and sells in-vitro diagnostics (IVD) products and services in China and internationally.

Hvsen Biotechnology

Market Cap: CN¥4.5b

Engages in the research and development, and manufacture of macrolides APIs and preparations in China and internationally.

Essex Bio-Technology

Market Cap: HK$2.4b

An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.

SIGA Technologies

Market Cap: US$595.0m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

Tong Ren Tang Technologies

Market Cap: HK$5.9b

Produces and distributes Chinese medicine products in Mainland China and Hong Kong.

Harmony Biosciences Holdings

Market Cap: US$1.7b

A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.

Gyre Therapeutics

Market Cap: US$694.8m

A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.

Newron Pharmaceuticals

Market Cap: CHF 288.2m

A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

Faes Farma

Market Cap: €1.4b

Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally.

Sawai Group Holdings

Market Cap: JP¥212.4b

Together with subsidiaries, engages in the research and development, manufacture, and marketing of generic pharmaceuticals.

Pharma Mar

Market Cap: €1.3b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, China, Germany, Ireland, France, rest of the European Union, the United States, and internationally.

Clinuvel Pharmaceuticals

Market Cap: AU$577.3m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

Niagen Bioscience

Market Cap: US$568.2m

Operates as a bioscience company engages in developing healthy aging products.

Medtide

Market Cap: HK$4.3b

A contract research, development, and manufacturing company, provides early-stage discovery, preclinical research, clinical development, and commercial-stage production services.

JBM (Healthcare)

Market Cap: HK$2.4b

An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.

Beijing Kawin Technology Share-Holding

Market Cap: CN¥4.8b

A biopharmaceutical company, provides treatment solutions for viral and immune diseases in China.

Takara Bio

Market Cap: JP¥111.1b

Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.

Jiangsu Sinopep-Allsino Biopharmaceutical

Market Cap: CN¥12.3b

A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.

Fine Foods & Pharmaceuticals N.T.M

Market Cap: €227.4m

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Amoy Diagnostics

Market Cap: CN¥8.8b

Engages in the development and commercialization of diagnostics product for oncology in China and internationally.

Photocure

Market Cap: NOK 1.5b

Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.

Zeria Pharmaceutical

Market Cap: JP¥88.2b

Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally.